NASDAQ:SCHN - Nasdaq - US8068821060 - Common Stock - Currency: USD
33.2
-0.19 (-0.57%)
The current stock price of SCHN is 33.2 USD. In the past month the price decreased by -2.78%. In the past year, price increased by 2.88%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VALE | VALE SA-SP ADR | 7.38 | 43.46B | ||
NUE | NUCOR CORP | 22.92 | 32.58B | ||
MT | ARCELORMITTAL-NY REGISTERED | 11.96 | 28.77B | ||
STLD | STEEL DYNAMICS INC | 18.55 | 18.89B | ||
PKX | POSCO HOLDINGS INC -SPON ADR | 33.95 | 18.18B | ||
RS | RELIANCE INC | 21.53 | 15.92B | ||
CRS | CARPENTER TECHNOLOGY | 38.69 | 13.66B | ||
ATI | ATI INC | 34.66 | 13.25B | ||
TX | TERNIUM SA-SPONSORED ADR | 17.27 | 6.17B | ||
GGB | GERDAU SA -SPON ADR | 9.29 | 6.14B | ||
CMC | COMMERCIAL METALS CO | 19.54 | 5.86B | ||
CLF | CLEVELAND-CLIFFS INC | N/A | 5.36B |
Schnitzer Steel Industries, Inc. engages in the recycling of ferrous and nonferrous scrap metal and manufacture of finished steel products. The company is headquartered in Boston, Massachusetts and currently employs 3,471 full-time employees. The firm is focused on developing and commercializing endocrine therapeutics. Its lead product, TYMLOS (abaloparatide) injection, is a prescription medicine for the treatment of postmenopausal women with osteoporosis at high risk for fracture. The firm also has products in clinical pipeline, which includes investigational abaloparatide injection for potential use in the treatment of men with osteoporosis; an investigational abaloparatide patch for potential use in the treatment of postmenopausal women with osteoporosis; the investigational drug, elacestrant (RAD1901), for potential use in the treatment of hormone-receptor positive breast cancer out-licensed to Menarini Group, and RAD011, a synthetic cannabidiol oral solution that is being developed for the treatment of Prader-Willi syndrome (PWS).
SCHNITZER STEEL INDS INC-A
22 Boston Wharf Road, 7Th Floor
Boston MASSACHUSETTS 97201 US
CEO: Tamara L. Lundgren
Employees: 3471
Phone: 15032249900.0
The current stock price of SCHN is 33.2 USD. The price decreased by -0.57% in the last trading session.
The exchange symbol of SCHNITZER STEEL INDS INC-A is SCHN and it is listed on the Nasdaq exchange.
SCHN stock is listed on the Nasdaq exchange.
9 analysts have analysed SCHN and the average price target is 35.7 USD. This implies a price increase of 7.53% is expected in the next year compared to the current price of 33.2. Check the SCHNITZER STEEL INDS INC-A stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SCHNITZER STEEL INDS INC-A (SCHN) has a market capitalization of 906.73M USD. This makes SCHN a Small Cap stock.
SCHNITZER STEEL INDS INC-A (SCHN) currently has 3471 employees.
SCHNITZER STEEL INDS INC-A (SCHN) has a support level at 33.17 and a resistance level at 34.34. Check the full technical report for a detailed analysis of SCHN support and resistance levels.
The Revenue of SCHNITZER STEEL INDS INC-A (SCHN) is expected to decline by -15.3% in the next year. Check the estimates tab for more information on the SCHN EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SCHNITZER STEEL INDS INC-A (SCHN) has a dividend yield of 2.52%. The yearly dividend amount is currently 0. Check the full fundamental report for a detailed analysis of SCHN dividend history, reliability and sustainability.
SCHNITZER STEEL INDS INC-A (SCHN) will report earnings on 2023-10-23, before the market open.
The PE ratio for SCHNITZER STEEL INDS INC-A (SCHN) is 38.16. This is based on the reported non-GAAP earnings per share of 0.87 and the current share price of 33.2 USD. Check the full fundamental report for a full analysis of the valuation metrics for SCHN.
ChartMill assigns a technical rating of 6 / 10 to SCHN. When comparing the yearly performance of all stocks, SCHN is one of the better performing stocks in the market, outperforming 74.13% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to SCHN. While SCHN seems to be doing ok healthwise, there are quite some concerns on its profitability.
Over the last trailing twelve months SCHN reported a non-GAAP Earnings per Share(EPS) of 0.87. The EPS decreased by -88.18% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 0.34% | ||
ROA | 0.56% | ||
ROE | 1.11% | ||
Debt/Equity | 0.37 |
ChartMill assigns a Buy % Consensus number of 49% to SCHN. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of -87.36% and a revenue growth -15.3% for SCHN